Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP.
暂无分享,去创建一个
M. Pooga | Ü. Langel | Ly Porosk | Piret Arukuusk | K. Kurrikoff | K. Padari | Kaisa Põhako | Kristina Kiisholts
[1] Li Li,et al. Design of a new pH‐activatable cell‐penetrating peptide for drug delivery into tumor cells , 2019, Chemical biology & drug design.
[2] I. V. Chernikov,et al. Current Development of siRNA Bioconjugates: From Research to the Clinic , 2019, Front. Pharmacol..
[3] A. Mason,et al. Histidine‐rich designer peptides of the LAH4 family promote cell delivery of a multitude of cargo , 2017, Journal of peptide science : an official publication of the European Peptide Society.
[4] M. Pooga,et al. Saturated Fatty Acid Analogues of Cell-Penetrating Peptide PepFect14: Role of Fatty Acid Modification in Complexation and Delivery of Splice-Correcting Oligonucleotides. , 2017, Bioconjugate chemistry.
[5] T. Tenson,et al. The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides , 2017, Molecular therapy. Nucleic acids.
[6] Zhao Meng,et al. Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery. , 2017, Journal of materials chemistry. B.
[7] Takashi Iwasaki,et al. Short polyhistidine peptides penetrate effectively into Nicotiana tabacum-cultured cells and Saccharomyces cerevisiae cells , 2017, Bioscience, biotechnology, and biochemistry.
[8] M. Pooga,et al. Optimization of in vivo DNA delivery with NickFect peptide vectors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[9] Sourav Bhattacharjee,et al. DLS and zeta potential - What they are and what they are not? , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[10] M. Hällbrink,et al. pH-responsive PepFect cell-penetrating peptides. , 2016, International journal of pharmaceutics.
[11] M. Pooga,et al. Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles. , 2016, Molecular pharmaceutics.
[12] J. DeSimone,et al. Reductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo. , 2015, Molecular pharmaceutics.
[13] Pu Chen,et al. Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide , 2015, International journal of nanomedicine.
[14] Yong Ren,et al. Recent advances in nanoparticle-mediated siRNA delivery. , 2014, Annual review of biomedical engineering.
[15] M. Castanho,et al. Cell‐penetrating peptides: A tool for effective delivery in gene‐targeted therapies , 2014, IUBMB life.
[16] G. Nienhaus,et al. Engineered nanoparticles interacting with cells: size matters , 2014, Journal of Nanobiotechnology.
[17] Jie Tang,et al. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. , 2013, Biomaterials.
[18] Ű. Langel,et al. Differential endosomal pathways for radically modified peptide vectors. , 2013, Bioconjugate chemistry.
[19] Yasumasa Kato,et al. Acidic extracellular microenvironment and cancer , 2013, Cancer Cell International.
[20] I. Nabi,et al. Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[21] Baoling Chen,et al. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake. , 2012, The journal of physical chemistry. B.
[22] Justin H Lo,et al. Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery , 2012, ACS nano.
[23] Ernst Wagner,et al. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[24] D. Scherman,et al. Control of pH responsive peptide self-association during endocytosis is required for effective gene transfer. , 2012, Biochimica et biophysica acta.
[25] M. Pooga,et al. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] E. Vázquez,et al. Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine , 2011, Microbial cell factories.
[27] Kairong Wang,et al. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. , 2011, Bioconjugate chemistry.
[28] L. Gentilucci,et al. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. , 2010, Current pharmaceutical design.
[29] R. Brasseur,et al. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] M. Morris,et al. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.
[31] Zheng-Rong Lu,et al. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. , 2007, Bioconjugate chemistry.
[32] A. Kichler,et al. Self-promoted cellular uptake of peptide/DNA transfection complexes. , 2007, Biochemistry.
[33] Simon W. Jones,et al. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. , 2007, Bioconjugate chemistry.
[34] Phillip D. Zamore,et al. RNA silencing: Genomic defence with a slice of pi , 2007, Nature.
[35] A. J. Mixson,et al. Highly branched HK peptides are effective carriers of siRNA , 2005, The journal of gene medicine.
[36] J. Strominger,et al. A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.